These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 26581593)

  • 21. Pharmacological promotion of autophagy alleviates steatosis and injury in alcoholic and non-alcoholic fatty liver conditions in mice.
    Lin CW; Zhang H; Li M; Xiong X; Chen X; Chen X; Dong XC; Yin XM
    J Hepatol; 2013 May; 58(5):993-9. PubMed ID: 23339953
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combined treatment with FABP4 inhibitor ameliorates rosiglitazone-induced liver steatosis in obese diabetic db/db mice.
    Chen MT; Huang JS; Gao DD; Li YX; Wang HY
    Basic Clin Pharmacol Toxicol; 2021 Sep; 129(3):173-182. PubMed ID: 34128319
    [TBL] [Abstract][Full Text] [Related]  

  • 23. p38 mitogen-activated protein kinase-dependent activation of protein phosphatases 1 and 2A inhibits MEK1 and MEK2 activity and collagenase 1 (MMP-1) gene expression.
    Westermarck J; Li SP; Kallunki T; Han J; Kähäri VM
    Mol Cell Biol; 2001 Apr; 21(7):2373-83. PubMed ID: 11259586
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Calpain 2-mediated autophagy defect increases susceptibility of fatty livers to ischemia-reperfusion injury.
    Zhao Q; Guo Z; Deng W; Fu S; Zhang C; Chen M; Ju W; Wang D; He X
    Cell Death Dis; 2016 Apr; 7(4):e2186. PubMed ID: 27077802
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Liver fibrosis protects mice from acute hepatocellular injury.
    Bourbonnais E; Raymond VA; Ethier C; Nguyen BN; El-Leil MS; Meloche S; Bilodeau M
    Gastroenterology; 2012 Jan; 142(1):130-139.e4. PubMed ID: 21945831
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Methionine and S-adenosylmethionine levels are critical regulators of PP2A activity modulating lipophagy during steatosis.
    Zubiete-Franco I; García-Rodríguez JL; Martínez-Uña M; Martínez-Lopez N; Woodhoo A; Juan VG; Beraza N; Lage-Medina S; Andrade F; Fernandez ML; Aldámiz-Echevarría L; Fernández-Ramos D; Falcon-Perez JM; Lopitz-Otsoa F; Fernandez-Tussy P; Barbier-Torres L; Luka Z; Wagner C; García-Monzón C; Lu SC; Aspichueta P; Mato JM; Martínez-Chantar ML; Varela-Rey M
    J Hepatol; 2016 Feb; 64(2):409-418. PubMed ID: 26394163
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Autophagy dysregulation caused by ApoM deficiency plays an important role in liver lipid metabolic disorder.
    Zhang X; Zhang P; Gao J; Huang Q
    Biochem Biophys Res Commun; 2018 Jan; 495(4):2643-2648. PubMed ID: 29288662
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacological inhibition of diacylglycerol acyltransferase 1 reduces body weight gain, hyperlipidemia, and hepatic steatosis in db/db mice.
    Zhang XD; Yan JW; Yan GR; Sun XY; Ji J; Li YM; Hu YH; Wang HY
    Acta Pharmacol Sin; 2010 Nov; 31(11):1470-7. PubMed ID: 21052084
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Leptin-mediated reactive oxygen species production does not significantly affect primary mouse hepatocyte functions in vitro.
    Schroyen B; Guimarães EL; Dollé L; Coulon S; Empsen C; Nyssen M; Geerts A; Colle I; Geerts A; van Grunsven LA
    Eur J Gastroenterol Hepatol; 2012 Dec; 24(12):1370-80. PubMed ID: 22895388
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ERK activation and autophagy impairment are central mediators of irinotecan-induced steatohepatitis.
    Mahli A; Saugspier M; Koch A; Sommer J; Dietrich P; Lee S; Thasler R; Schulze-Luehrmann J; Luehrmann A; Thasler WE; Müller M; Bosserhoff A; Hellerbrand C
    Gut; 2018 Apr; 67(4):746-756. PubMed ID: 28053052
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alpha7 nAChR-mediated activation of MAP kinase pathways in PC12 cells.
    Gubbins EJ; Gopalakrishnan M; Li J
    Brain Res; 2010 Apr; 1328():1-11. PubMed ID: 20211606
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Resveratrol improves hepatic steatosis by inducing autophagy through the cAMP signaling pathway.
    Zhang Y; Chen ML; Zhou Y; Yi L; Gao YX; Ran L; Chen SH; Zhang T; Zhou X; Zou D; Wu B; Wu Y; Chang H; Zhu JD; Zhang QY; Mi MT
    Mol Nutr Food Res; 2015 Aug; 59(8):1443-57. PubMed ID: 25943029
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ERK1/2 is involved in luteal cell autophagy regulation during corpus luteum regression via an mTOR-independent pathway.
    Choi J; Jo M; Lee E; Choi D
    Mol Hum Reprod; 2014 Oct; 20(10):972-80. PubMed ID: 25107837
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Kupffer cells facilitate the acute effects of leptin on hepatic lipid metabolism.
    Metlakunta A; Huang W; Stefanovic-Racic M; Dedousis N; Sipula I; O'Doherty RM
    Am J Physiol Endocrinol Metab; 2017 Jan; 312(1):E11-E18. PubMed ID: 27827807
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interleukin 6 alleviates hepatic steatosis and ischemia/reperfusion injury in mice with fatty liver disease.
    Hong F; Radaeva S; Pan HN; Tian Z; Veech R; Gao B
    Hepatology; 2004 Oct; 40(4):933-41. PubMed ID: 15382116
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activation of free fatty acid receptor 1 improves hepatic steatosis through a p38-dependent pathway.
    Ou HY; Wu HT; Lu FH; Su YC; Hung HC; Wu JS; Yang YC; Wu CL; Chang CJ
    J Mol Endocrinol; 2014 Oct; 53(2):165-74. PubMed ID: 25008074
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The constitutive lipid droplet protein PLIN2 regulates autophagy in liver.
    Tsai TH; Chen E; Li L; Saha P; Lee HJ; Huang LS; Shelness GS; Chan L; Chang BH
    Autophagy; 2017 Jul; 13(7):1130-1144. PubMed ID: 28548876
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Extracellular signal-regulated kinase 1/2 mitogen-activated protein kinase pathway is involved in myostatin-regulated differentiation repression.
    Yang W; Chen Y; Zhang Y; Wang X; Yang N; Zhu D
    Cancer Res; 2006 Feb; 66(3):1320-6. PubMed ID: 16452185
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatic hyperplasia in noncirrhotic fatty livers: is obesity-related hepatic steatosis a premalignant condition?
    Yang S; Lin HZ; Hwang J; Chacko VP; Diehl AM
    Cancer Res; 2001 Jul; 61(13):5016-23. PubMed ID: 11431335
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Citrus unshiu peel extract ameliorates hyperglycemia and hepatic steatosis by altering inflammation and hepatic glucose- and lipid-regulating enzymes in db/db mice.
    Park HJ; Jung UJ; Cho SJ; Jung HK; Shim S; Choi MS
    J Nutr Biochem; 2013 Feb; 24(2):419-27. PubMed ID: 22694954
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.